These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 1101814

  • 1. In vitro studies with combinations of 5-fluorocytosine and amphotericin B.
    Shadomy S, Wagner G, Espinel-Ingroff E, Davis BA.
    Antimicrob Agents Chemother; 1975 Aug; 8(2):117-21. PubMed ID: 1101814
    [Abstract] [Full Text] [Related]

  • 2. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
    Chen HH, Liushih RN, Hsieh WC.
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
    [Abstract] [Full Text] [Related]

  • 3. Assay for yeast susceptibility to 5-fluorocytosine and amphotericin B in a frozen microtiter system.
    Ellis NS, Bartlett MS, Smith JW.
    Am J Clin Pathol; 1979 Aug; 72(2):194-8. PubMed ID: 382827
    [Abstract] [Full Text] [Related]

  • 4. Synergism of amphotericin B and 5-fluorocytosine for candida species.
    Montgomerie JZ, Edwards JE, Guze LB.
    J Infect Dis; 1975 Jul; 132(1):82-6. PubMed ID: 1097545
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of amphotericin B and flucytosine in combination against Candida albicans and Cryptococcus neoformans using time-kill methodology.
    Keele DJ, DeLallo VC, Lewis RE, Ernst EJ, Klepser ME.
    Diagn Microbiol Infect Dis; 2001 Nov; 41(3):121-6. PubMed ID: 11750164
    [Abstract] [Full Text] [Related]

  • 6. Synergism of polyene antibiotics with 5-fluorocytosine.
    Polak A.
    Chemotherapy; 1978 Nov; 24(1):2-16. PubMed ID: 338264
    [Abstract] [Full Text] [Related]

  • 7. Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole.
    Hoeprich PD, Huston AC.
    J Infect Dis; 1975 Aug; 132(2):133-41. PubMed ID: 1099147
    [Abstract] [Full Text] [Related]

  • 8. Combined action of amphotericin B and 5-fluorocytosine on pathogenic yeasts susceptible to either drug alone.
    Beggs WH, Andrews FA, Sarosi GA.
    Chemotherapy; 1981 Aug; 27(4):247-51. PubMed ID: 7195793
    [Abstract] [Full Text] [Related]

  • 9. Antifungal activity of 5-fluorocytosine as measured by disk diffusion susceptibility testing.
    Utz CJ, Shadomy S.
    J Infect Dis; 1977 Jun; 135(6):970-4. PubMed ID: 325150
    [Abstract] [Full Text] [Related]

  • 10. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
    Morace G, Manzara S, Dettori G.
    Chemotherapy; 1991 Jun; 37(1):23-31. PubMed ID: 2013239
    [Abstract] [Full Text] [Related]

  • 11. Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.
    Odds FC.
    Antimicrob Agents Chemother; 1982 Nov; 22(5):763-70. PubMed ID: 6295266
    [Abstract] [Full Text] [Related]

  • 12. Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts.
    Doern GV, Tubert TA, Chapin K, Rinaldi MG.
    J Clin Microbiol; 1986 Oct; 24(4):507-11. PubMed ID: 3533974
    [Abstract] [Full Text] [Related]

  • 13. Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and Candida spp.
    Rossi SA, de Oliveira HC, Agreda-Mellon D, Lucio J, Mendes-Giannini MJS, García-Cambero JP, Zaragoza O.
    Antimicrob Agents Chemother; 2020 Mar 24; 64(4):. PubMed ID: 31988099
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms of synergistic interactions between amphotericin B and flucytosine.
    Beggs WH.
    J Antimicrob Chemother; 1986 Apr 24; 17(4):402-4. PubMed ID: 3519560
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of microdilution and broth dilution techniques for the susceptibility testing of yeasts to 5-fluorocytosine and amphotericin B.
    Mazens MF, Andrews GP, Bartlett RC.
    Antimicrob Agents Chemother; 1979 Mar 24; 15(3):475-7. PubMed ID: 464576
    [Abstract] [Full Text] [Related]

  • 16. In vitro determination of optimal antifungal combinations against Cryptococcus neoformans and Candida albicans.
    Ghannoum MA, Fu Y, Ibrahim AS, Mortara LA, Shafiq MC, Edwards JE, Criddle RS.
    Antimicrob Agents Chemother; 1995 Nov 24; 39(11):2459-65. PubMed ID: 8585726
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.